SCHEMBL5409308

SCHEMBL5409308

CCO[C@@H](Cc1ccc(OS(=O)(=O)C(F)(F)F)cc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.63
PPARG P37231 14/20 0.63
PPARD Q03181 12/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5365330 0.90 PPARG (0.53) PPARAPPARGPPARD
SCHEMBL5365342 0.83 PPARA (0.46) PPARAPPARGPPARD
SCHEMBL6575581 0.82 PPARG (0.45) PPARAPPARGPPARD
SCHEMBL5375683 0.82 PPARG (0.45) PPARAPPARGPPARD
SCHEMBL4652349 0.80 CXCR2 (0.50) PPARAPPARGPPARD
SCHEMBL6055973 0.80 PPARA (0.73) PPARAPPARGPPARD
SCHEMBL4455247 0.80 PPARA (0.73) PPARAPPARGPPARD
SCHEMBL4460245 0.79 PPARA (0.68) PPARAPPARGPPARD
SCHEMBL4460251 0.79 PPARA (0.68) PPARAPPARGPPARD
SCHEMBL7617610 0.79 PPARA (0.72) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241923-B2 Phenylalkyloxy-phenyl derivatives ASTRAZENECA AB (SE) 2007-07-10 US disclosed
EP-1638926-A1 2-ETHOXY-3-PHENYLPROPIONIC ACID DERIVATIVES FOR THE TREATMENT OF LIPID DISORDERS Astrazeneca AB (SE) 2006-03-29 EP disclosed
WO-2004113276-A1 2-ETHOXY-3-PHENYLPROPIONIC ACID DERIVATIVES FOR THE TREATMENT OF LIPID DISORDERS ASTRAZENECA AB (SE) 2004-12-29 WO disclosed
US-20040176444-A1 Phenylalkyloxy-phenyl derivatives ASTRAZENECA AB (SE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176444-A1 Phenylalkyloxy-phenyl derivatives GPR119, IAPP, INSR PPARA 87/4885PPARG 53/4885PPARD 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.